https://www.selleckchem.com/pr....oducts/Methazolaston
0 day at weeks 4 and 8, P0.001), the number of consumed pain-relief medications (-1.0 at weeks 4 and 8, P0.001), and systemic symptoms severity (-1.0 score at weeks 4 and 8, P0.001). No significant improvements were observed in the placebo group in terms of these outcomes. Vitamin D supplementation in women with primary dysmenorrhea and vitamin D deficiency could improve systemic symptoms and reduce pain intensity, the number of days with pain, and the need for consuming pain-relief medications. Vitamin D supplementat
Like
Comment
Share
